NASDAQ:CHRS | Operating Income | Coherus Oncology, Inc.

Complete source-backed operating income history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$32.33M
2026-03-31-$36.15M
2025-12-31-$45.88M
2025-09-30-$44.33M
2025-06-30-$45.49M
2025-03-31-$45.44M
2024-12-31-$45.38M
2024-09-30-$46.86M
2024-06-30-$39.63M
2024-03-31-$67.79M
2023-12-31-$68.91M
2023-09-30-$32.01M
2023-06-30-$34.54M
2023-03-31-$67.75M
2022-12-31-$51.49M
2022-09-30-$80.45M
2022-06-30-$44.01M
2022-03-31-$80.93M
2021-12-31-$39.55M
2021-09-30-$32.79M
2021-06-30-$24.16M
2021-03-31-$167.36M
2020-12-31$16.43M
2020-09-30$33.72M
2020-06-30$65.31M
2020-03-31$40.87M
2019-12-31$45.03M
2019-09-30$51.84M
2019-06-30$27.49M
2019-03-31-$16.6M
2018-12-31-$60.5M
2018-09-30-$56.97M
2018-06-30-$44.91M
2018-03-31-$42.03M
2017-12-31-$46.47M
2017-09-30-$56.62M
2017-06-30-$56.64M
2017-03-31-$72.42M
2016-12-31-$73.46M
2016-09-30$84.62M
2016-06-30-$62.74M
2016-03-31-$64.35M
2015-12-31-$52.21M
2015-09-30-$71.22M
2015-06-30-$58.9M
2015-03-31-$36.75M
2014-12-31-$26.56M
2014-09-30-$6.42M
2014-06-30-$17.94M
2014-03-31-$13.76M
2013-12-31-$10.49M
2013-09-30-$6.78M

Annual Operating Income

DateOperating Income
2025-12-31-$181.13M
2024-12-31-$199.65M
2023-12-31-$203.2M
2022-12-31-$256.88M
2021-12-31-$263.86M
2020-12-31$156.32M
2019-12-31$107.77M
2018-12-31-$204.42M
2017-12-31-$232.14M
2016-12-31-$115.93M
2015-12-31-$219.07M
2014-12-31-$64.68M
2013-12-31-$35.99M
2012-12-31-$38.52M